Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of BZ371A Gel in Healthy Volunteers
NCT05332340Phase 1Completed
- Sponsor
- Biozeus
- Start
- Nov 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of bz371a in erectile dysfunction (ED), sponsored by Biozeus. Primary endpoints: Maximum Plasma Concentration, Half-Life and 12 more. Started Nov 2022; status: completed.
02
Drugs
bz371a
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT05332340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05332340.